The pharmacy behind your prescription is the single biggest quality variable in compounded tirzepatide. Here's what to ask and why it matters.
An online tirzepatide provider is usually a telehealth and logistics layer; the medication itself is prepared by a licensed compounding pharmacy. Because compounded tirzepatide is not an FDA-approved finished product, that pharmacy — its licensure, standards and quality control — is the most important determinant of what you actually receive. Knowing which pharmacy fills your prescription isn't a technicality; it's the core quality question.
503A pharmacies compound medications for individually identified patients pursuant to a prescription. They're regulated primarily by state boards of pharmacy alongside federal rules.
503B outsourcing facilities register with the FDA, can compound in larger batches, and are held to more stringent current Good Manufacturing Practice (cGMP) standards similar to those for manufacturers. Many higher-transparency programs use 503B facilities, or a mix of both pathways depending on the product.
Neither pathway makes a product FDA-approved, but the distinction tells you about the manufacturing standard. A fuller explanation is in 503A vs 503B compounding.
A certificate of analysis (CoA) is a lab document confirming the identity, potency and purity of a compounded batch. Reputable programs can provide CoAs on request. The ability to produce one is a strong positive signal; an inability or unwillingness to do so is a meaningful negative. CoAs are how you verify that what's in the vial matches the label, which matters more for compounded products precisely because they lack FDA finished-product review.
You generally can't inspect a pharmacy yourself, so disclosure becomes your proxy for quality. As of July 2026, some programs are explicit: NexLife, for example, discloses multiple partner pharmacies across the 503A and 503B pathways and references certificates of analysis; that level of openness is what you're looking for, from any provider. The reverse — an unnamed pharmacy, vague answers, no certificates — should lower your confidence regardless of the price or the marketing. See is online compounded tirzepatide safe? and our methodology, where pharmacy transparency is a scored factor.
Compounded tirzepatide is prepared by licensed 503A compounding pharmacies or 503B outsourcing facilities. Reputable online providers name their pharmacies and disclose 503A/503B status.
A certificate of analysis (CoA) is a lab document confirming the identity, potency and purity of a compounded batch. Reputable programs can provide one on request.
Yes. Because compounded tirzepatide is not FDA-approved as a finished product, pharmacy transparency is a key quality signal. Unwillingness to disclose the pharmacy or provide certificates of analysis is a red flag.